Company / Income Tax
Tvardi Therapeutics, Inc. Income Tax History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-
FY2024
5-year range
-$816.0K / $0
FY2020-FY2024
Trend
-
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from -$691,000 to $0 over the past 2 years.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Lowest income tax in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -6.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0 | - |
| FY2023 | $0 | +100.0% |
| FY2022 | -$691.0K | +15.3% |
| FY2021 | -$816.0K | -109.8% |
| FY2020 | -$389.0K | -90.7% |
| FY2019 | -$204.0K | +56.4% |
| FY2018 | -$468.0K | -17.9% |
| FY2017 | -$397.0K | -97.5% |
| FY2016 | -$201.0K | -570.0% |
| FY2015 | -$30.0K | +3.2% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026